| Dr Elizabeth Hyde Prichard, MD | |
|
920 Church St N, Concord, NC 28025-2927 | |
| (704) 403-3000 | |
| Not Available |
| Full Name | Dr Elizabeth Hyde Prichard |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 38 Years |
| Location | 920 Church St N, Concord, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760474050 | NPI | - | NPPES |
| 8969261 | Medicaid | NC | |
| 69261 | Other | NC | BCBS OF NC |
| 220016451 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 32249 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center-northeast | Concord, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cabarrus Pathology Associates Pa | 9436121324 | 7 |
News Archive
A simple blood test is allowing Vanderbilt University Medical Cente researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
Young women, ages 55 years or below, are more likely to be hospitalized for an acute myocardial infarction (AMI) and to die within the first 30 days than men in the same age group, according to a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
Legislation that could push more than 100,000 low-income senior citizens in Massachusetts into managed care health plans spurred intense lobbying yesterday, as consumer advocates argued the measure would strip patients of their freedom to stay in traditional Medicare, while proponents said it could save the state significant money.
A recent study examines the relationship among public health behaviors during the COVID-19 pandemic and social capital indices in the United States.
› Verified 4 days ago
| Entity Name | Cabarrus Gastroenterology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780790592 PECOS PAC ID: 9436059649 Enrollment ID: O20040113000342 |
News Archive
A simple blood test is allowing Vanderbilt University Medical Cente researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
Young women, ages 55 years or below, are more likely to be hospitalized for an acute myocardial infarction (AMI) and to die within the first 30 days than men in the same age group, according to a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
Legislation that could push more than 100,000 low-income senior citizens in Massachusetts into managed care health plans spurred intense lobbying yesterday, as consumer advocates argued the measure would strip patients of their freedom to stay in traditional Medicare, while proponents said it could save the state significant money.
A recent study examines the relationship among public health behaviors during the COVID-19 pandemic and social capital indices in the United States.
› Verified 4 days ago
| Entity Name | Cabarrus Pathology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538131800 PECOS PAC ID: 9436121324 Enrollment ID: O20040811000348 |
News Archive
A simple blood test is allowing Vanderbilt University Medical Cente researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
Young women, ages 55 years or below, are more likely to be hospitalized for an acute myocardial infarction (AMI) and to die within the first 30 days than men in the same age group, according to a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
Legislation that could push more than 100,000 low-income senior citizens in Massachusetts into managed care health plans spurred intense lobbying yesterday, as consumer advocates argued the measure would strip patients of their freedom to stay in traditional Medicare, while proponents said it could save the state significant money.
A recent study examines the relationship among public health behaviors during the COVID-19 pandemic and social capital indices in the United States.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Hyde Prichard, MD Po Box 409, Bluefield, WV 24701-0409 Ph: () - | Dr Elizabeth Hyde Prichard, MD 920 Church St N, Concord, NC 28025-2927 Ph: (704) 403-3000 |
News Archive
A simple blood test is allowing Vanderbilt University Medical Cente researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.
Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement") with MAST BioSurgery Inc. ("MAST") for the development of one or more new surgical products incorporating Ceragenix's CeraShield™ antimicrobial technology.
Young women, ages 55 years or below, are more likely to be hospitalized for an acute myocardial infarction (AMI) and to die within the first 30 days than men in the same age group, according to a new study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.
Legislation that could push more than 100,000 low-income senior citizens in Massachusetts into managed care health plans spurred intense lobbying yesterday, as consumer advocates argued the measure would strip patients of their freedom to stay in traditional Medicare, while proponents said it could save the state significant money.
A recent study examines the relationship among public health behaviors during the COVID-19 pandemic and social capital indices in the United States.
› Verified 4 days ago
Kapil Gupta, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 335 Penny Ln, Concord, NC 28025 Phone: 704-784-5901 Fax: 704-721-0413 | |
Dr. Ryan Christopher Romano, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-403-3000 | |
Dr. Carl Louis Buckner, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-403-3100 | |
Dr. William Andrew Evans, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-783-1542 | |
Dr. Christine Frances Piller, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-783-1542 | |
Nicholas Hai Mai, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 920 Church St N, Concord, NC 28025 Phone: 704-403-3000 |